default author photo

Francisco José Martínez-Martínez

Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit

SCHOLARLY PAPERS

2

DOWNLOADS

240

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Genomic Determinants of Antibiotic Resistance for Helicobacter Pylori Treatment

Number of pages: 47 Posted: 23 Dec 2024
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, FISABIO-Public Health, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Baylor University, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), University of Bordeaux, Baylor University, Baylor University, University of Bordeaux, University of Bordeaux, University of Bordeaux, Government of the United States of America - National Cancer Institute, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, University of Bordeaux and Government of the United States of America - Division of Cancer Epidemiology and Genetics
Downloads 144 (511,933)
Citation 1

Abstract:

Loading...

Helicobacter pylori, long-read sequencing, pAST, gAST, clarithromycin, levofloxacin, antimicrobial resistance, resistance prevalence

2.

Genomic Surveillance of SARS-CoV-2 in Mozambique Using Pandemic-Scale Phylogenies

Number of pages: 20 Posted: 27 Sep 2022
Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centro de Investigação em Saúde da Manhiça (CISM), Centro de Investigação em Saúde da Manhiça (CISM), Centro de Investigação em Saúde da Manhiça (CISM), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Universitat de Barcelona, Centro de Investigação em Saúde da Manhiça (CISM), Centro de Investigação em Saúde da Manhiça (CISM), Hospital Distrital da Manhiça, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit, Centro de Investigação em Saúde da Manhiça (CISM), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) - Tuberculosis Genomics Unit and Centro de Investigação em Saúde da Manhiça (CISM)
Downloads 96 (709,832)

Abstract:

Loading...